Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Ocugen Inc (OCGN)

Ocugen Inc (OCGN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 353,217
  • Shares Outstanding, K 162,026
  • Annual Sales, $ 0 K
  • Annual Income, $ -20,240 K
  • 60-Month Beta 3.56
  • Price/Sales 4,045.28
  • Price/Cash Flow N/A
  • Price/Book 25.28
Trade OCGN with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate -0.02
  • Number of Estimates 2
  • High Estimate -0.02
  • Low Estimate -0.02
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.61 +35.40%
on 12/24/20
3.50 -37.71%
on 01/04/21
+1.37 (+170.74%)
since 12/22/20
3-Month
0.25 +771.65%
on 11/02/20
3.50 -37.71%
on 01/04/21
+1.86 (+581.25%)
since 10/22/20
52-Week
0.17 +1,182.35%
on 06/01/20
3.50 -37.71%
on 01/04/21
+1.47 (+208.35%)
since 01/22/20

Most Recent Stories

More News
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ocugen, Inc. - OCGN

New York, New York--(Newsfile Corp. - January 20, 2021) - Pomerantz LLP is investigating claims on behalf of investors of Ocugen, Inc.("Ocugen" or the "Company") (NASDAQ: OCGN). Such investors are advised...

OCGN : 2.18 (-3.11%)
Ocugen Inc. Announces the Cancellation of Stockholder Meeting Previously Adjourned to 11:00 a.m. Eastern Time on January 13, 2021

Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to fight COVID-19, today...

OCGN : 2.18 (-3.11%)
Ocugen Inc. Regains Compliance with Nasdaq Bid Price Rule

Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to fight COVID-19, today...

OCGN : 2.18 (-3.11%)
Ocugen Inc. to Present at CTIC, HC Wainwright and Noble Capital Investor Conferences

Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and develop a vaccine to fight COVID-19, today...

OCGN : 2.18 (-3.11%)
Thinking about buying stock in BioNano Genomics, Ocugen, Acasti Pharma, Novan, or Transenterix?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BNGO, OCGN, ACST, NOVN, and TRXC.

TRXC : 3.71 (+14.51%)
BNGO : 9.80 (+18.50%)
NOVN : 1.3500 (-0.74%)
OCGN : 2.18 (-3.11%)
ACST : 0.8000 (-4.17%)
Thinking about buying stock in Ocugen, BioNano Genomics, FLIR Systems, Clearside Biomedical, or Viewray?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for OCGN, BNGO, FLIR, CLSD, and VRAY.

BNGO : 9.80 (+18.50%)
CLSD : 3.79 (+3.55%)
FLIR : 54.36 (+0.33%)
OCGN : 2.18 (-3.11%)
VRAY : 4.48 (-15.31%)
Thinking about buying stock in Novan, Fubotv, Zomedica, Riot Blockchain, or Ocugen?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NOVN, FUBO, ZOM, RIOT, and OCGN.

ZOM : 0.9562 (-4.38%)
NOVN : 1.3500 (-0.74%)
OCGN : 2.18 (-3.11%)
RIOT : 20.97 (+8.37%)
FUBO : 37.72 (+6.25%)
Thinking about buying stock in Gevo, Ocugen, Riot Blockchain, Matinas BioPharma, or Blink Charging?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for GEVO, OCGN, RIOT, MTNB, and BLNK.

MTNB : 1.5600 (-1.89%)
BLNK : 44.35 (-3.80%)
OCGN : 2.18 (-3.11%)
GEVO : 10.51 (+13.01%)
RIOT : 20.97 (+8.37%)
Thinking about buying stock in BioNano Genomics, Ocugen Inc, Biolase, Gevo, or FuelCell Energy?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BNGO, OCGN, BIOL, GEVO, and FCEL.

BNGO : 9.80 (+18.50%)
FCEL : 18.13 (+4.86%)
OCGN : 2.18 (-3.11%)
BIOL : 1.0400 (-4.59%)
GEVO : 10.51 (+13.01%)
Thinking about buying stock in Ocugen, Marathon, Phunware, Myovant Sciences, or Gevo?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for OCGN, MARA, PHUN, MYOV, and GEVO.

OCGN : 2.18 (-3.11%)
PHUN : 1.3200 (+2.33%)
GEVO : 10.51 (+13.01%)
MARA : 18.30 (+4.21%)
MYOV : 20.86 (+0.97%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Ocugen Inc. is a clinical stage biopharmaceutical company. It is focused on discovering, developing and commercializing therapies which address rare and underserved eye diseases. The company's product pipeline consists of OCU400, OCU300, OCU100 and OCU200 which are in clinical stage. Ocugen Inc., formerly...

See More

Key Turning Points

3rd Resistance Point 2.32
2nd Resistance Point 2.29
1st Resistance Point 2.23
Last Price 2.18
1st Support Level 2.14
2nd Support Level 2.11
3rd Support Level 2.05

See More

52-Week High 3.50
Fibonacci 61.8% 2.23
Last Price 2.18
Fibonacci 50% 1.84
Fibonacci 38.2% 1.44
52-Week Low 0.17

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar